je.st
news
Home
› FDA Approves New Drug Application (NDA) For Teva's Quartette (Levonorgestrel/Ethinyl Estradiol And Ethinyl Estradiol) Tablets For The Prevention Of Pregnancy
FDA Approves New Drug Application (NDA) For Teva's Quartette (Levonorgestrel/Ethinyl Estradiol And Ethinyl Estradiol) Tablets For The Prevention Of Pregnancy
2013-03-29 09:00:00| drugdiscoveryonline News Articles
Teva Pharmaceutical Industries Ltd. recently announced that the U.S. Food and Drug Administration (FDA) has approved Quartette™ (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets for the prevention of pregnancy
Tags: the
of
application
drug
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||